Samsung Bioepis accelerates development of new AI antibody drugs
⚡ Quick Summary
(Seoul = Yonhap News) Reporter Park Sang-hyun = Samsung Bioepis and life science company Protina [468530] are speeding up the development of new antibody drugs using artificial intelligence (AI)...
📰 Related Articles
Cerebras, a rival to NVIDIA, “invests trillions of won in Europe”
Yonhap
Hanmong strengthens cooperation in AI, energy, distribution and logistics... Join forces to prevent desertification and yellow dust
Yonhap
Construction Day celebration... Minister Kim Yun-deok "Creating an AI-based smart construction site" (comprehensive)
Yonhap[Science Technology/IT] Korea KAIST develops ‘stretchable screen’ that does not distort letters and images even when stretched
굿모닝베트남미디어
The meeting of Jikji and AI… Cheongju Jikji Cultural Festival opens on September 4th
Yonhap